Lexaria Bioscience Corp. — Director's Dealing 2010

Jan 22, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: Bhullar Baljinder (Director, CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-01-20	Stock Options	$0.2	P	300000	Acquired	2015-01-20	Common Shares (300000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	41250	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$0.2	2011-07-10	Common Shares (40000)	40000	Direct
Stock Options	$0.2	2011-07-20	Common Shares (12500)	12500	Direct
Stock Options	$0.2	2011-07-20	Common Shares (37500)	37500	Direct

Footnotes

F1: On July 8, 2009, the exercise price was changed from $0.12.